Navigation Links
Frost & Sullivan's 2009 Excellence in Healthcare Awards Banquet Honours Industry's Top Performers
Date:10/12/2009

LONDON, Oct. 12 /PRNewswire/ -- Outstanding performances in Europe's healthcare industry were recognised at Frost & Sullivan's '2009 Excellence in Healthcare Awards Banquet,' held in London on 8th October 2009. 17 leading companies were presented with awards at this prestigious event.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Recipients from a range of healthcare sectors, including drug discovery technologies, healthcare and life sciences IT, medical imaging and honourees were lauded for exceptional product innovation and differentiation, business development strategies and market leadership.

Frost & Sullivan's highly competitive awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

Delivering the keynote address on emerging Healthcare markets, Mr. Sumit Sharma, Senior Vice President (Global), Emerging Markets & New Business Healthcare Practice Director, Frost & Sullivan, said, "As the key Healthcare markets begin to saturate and the overall spending by the governments on Healthcare is challenged, the need for new markets and growth avenues become more important than ever before. One such opportunity is China. The recent reforms in China have resulted in the opening up of the doors for MNCs to penetrate more into this ever expanding and dynamic market. The biggest opportunities in China are being created by the increasing focus of urbanisation by the government that leads to improvements in the Healthcare systems for every strata of the population, sophistication of hospitals, improved IP regulations and the greater need for superior commercialisation plans. All in all, China promises to be the biggest growth opportunity for the Healthcare companies in the west, irrespective of their size."

Following this address was the evening's highlight - the awards presentation recognising outstanding performers in the healthcare arena over the past year:

  • Touch Bionics - 2009 European Bionic Limbs Hot Investment Opportunity Award
  • Ziehm Imaging - 2009 European Mobile C-Arms Business Development Strategy Leadership Award
  • ERGONEX Pharma - 2009 European Orphan Diseases Entrepreneurial Company Award
  • Mennen Medical Ltd - 2009 European Patient Monitoring Technology Leadership of the Year Award
  • TCLAND EXPRESSION - 2009 European Biomarker Discovery and Development Entrepreneurial Company of the Year Award
  • TCLAND EXPRESSION - 2009 European Gene Expression Biomarkers Technology Innovation Award
  • Cegedim Dendrite - 2009 World LifeSciences-IT Market Leadership Award
  • InterSystems - 2009 European Hospital Information System Customer Value Leadership Award
  • Anoto - 2009 European Care Management Systems Industry Innovation & Advancement Award
  • Viatronix Incorporated - 2009 European Medical Imaging Emerging Company of the Year Award
  • Phillips Healthcare - 2009 European Fluoroscopy Product Quality Leadership Award

The Frost & Sullivan Healthcare Awards Banquet honoured Europe's best healthcare companies for their achievements over the course of this year. At a time of global recession and recovery, these award winners have devised strategies to stay on top of their markets and realise competitive excellence.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Jasmine Malone
    Promotions Coordinator, Best Practices
    DDI: +44 (0) 207 915 7869
    Jasmine.malone@frost.com

SOURCE Frost & Sullivan


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
2. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
3. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
4. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
5. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
6. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
7. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
8. Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
9. Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
10. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
11. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):